Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1/2 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 4INDUSTRY 2NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Genitourinary 1

Conditions

Leukemia 16Carcinoma, Renal Cell 15Leukemia, Myeloid, Chronic-Phase 13Kidney Neoplasms 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Melanoma 8Multiple Myeloma 7Pancreatic Neoplasms 6Lymphoma 6Neoplasms, Plasma Cell 5Lymphoma, Follicular 5Neoplasms 4Lymphoma, Mantle-Cell 4Leukemia, Myeloid, Acute 4Leukemia, Myeloid, Accelerated Phase 4Carcinoma, Hepatocellular 4Waldenstrom Macroglobulinemia 3Urinary Bladder Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Lymphocytic, Chronic, B-Cell 3Stomach Neoplasms 2Skin Neoplasms 2Recurrence 2Polycythemia Vera 2Lymphoma, B-Cell, Marginal Zone 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2

Interventions

Surveys and Questionnaires 114Exercise 103Blood Specimen Collection 99Radiotherapy 67Gemcitabine 64Bevacizumab 57Standard of Care 56Cisplatin 55Cyclophosphamide 51Capecitabine 50Carboplatin 49Docetaxel 47pembrolizumab 46Dexamethasone 46Paclitaxel 45Interviews as Topic 43Oxaliplatin 40Magnetic Resonance Spectroscopy 39Fluorouracil 37Methods 36Irinotecan 36Therapeutics 33Drug Therapy 33Radiosurgery 31Nivolumab 30Erlotinib Hydrochloride 27Educational Status 26Everolimus 24Leucovorin 23Control Groups 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Neoplasms × Interferon-alpha × Clear all
NCT04534725 2023-08-24

C-SMART

Peter MacCallum Cancer Centre, Australia

Phase 3 Completed
441 enrolled

COVID-19, Neoplasms

NCT00277017 2011-09-27

Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma

New Mexico Cancer Research Alliance

Phase 1/2 Completed
15 enrolled
Genitourinary

Carcinoma, Renal Cell, Neoplasms

NCT00178763 2011-03-03

FR-WB-TT

The University of Texas Health Science Center, Houston

Phase 2 Unknown
36 enrolled
Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT00250796 2010-01-07

Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma

University of New Mexico

Phase 2 Completed
12 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡